| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/16/2006 | EP1689877A1 Fusion proteins and methods of cleavage of such proteins |
| 08/16/2006 | EP1689869A2 Recombinant microorganism |
| 08/16/2006 | EP1689867A1 Immunization against chlamydia infection |
| 08/16/2006 | EP1689848A2 Kahalalide-producing bacteria |
| 08/16/2006 | EP1689766A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 08/16/2006 | EP1689346A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 08/16/2006 | EP1581797A4 Methods for the detection, analysis and isolation of nascent proteins |
| 08/16/2006 | EP1495112B1 Cell culture medium |
| 08/16/2006 | EP1292687B1 Regulated antigen delivery system (rads) involving bacteria |
| 08/16/2006 | EP1268545B1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1186301B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
| 08/16/2006 | EP1115876B1 Receptor based antagonists and methods of making and using |
| 08/16/2006 | EP1064369B1 Nucleic acid binding proteins |
| 08/16/2006 | EP1064309B1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1053324B1 Novel cystine knot protein and materials and methods for making it |
| 08/16/2006 | EP0827509B1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1820080A Product quality enhancement in mammalian cell culture processes for protein production |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1819844A Immunogene adherence and method of making and using the same |
| 08/16/2006 | CN1817906A Antibody against human parathormone related peptides |
| 08/16/2006 | CN1817903A Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 08/16/2006 | CN1817902A Recombinant scorpion toxin, its soluble expression and purification |
| 08/16/2006 | CN1269965C Process for preparing serine-rich protein employing cysteine synthase (cysk) gene |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269839C Treatment with anti-ErbB2 antibodies |
| 08/16/2006 | CN1269838C Signal sequences for the production of Leu-hirudine via secretion by E. coli in a culture medium |
| 08/15/2006 | US7091330 Cloning and characterization of a CD2 binding protein (CD2BP2) |
| 08/15/2006 | US7091326 Fusion protein having enhanced in vivo erythropoietin activity |
| 08/15/2006 | US7091323 Human TIMP-1 antibodies |
| 08/15/2006 | US7091319 IL-3 variant hematopoiesis fusion protein |
| 08/15/2006 | US7091317 Enhanced green fluorescent protein for use as diagnostic tool in monitoring gene expression, function and localization |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091177 Bacillus thuringiensis isolates active against weevils |
| 08/15/2006 | US7091038 Ecdysone receptor-based inducible gene expression system |
| 08/15/2006 | US7091033 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression |
| 08/15/2006 | US7091029 Preparing adeno-associated viral vectors for gene therapeutic treatment of respiratory system disorders |
| 08/15/2006 | US7091025 Malathion carboxylesterase |
| 08/15/2006 | US7091019 The use of these proteins enables the transformation of a hop by gene manipulations as well as enables the in vitro synthesis of the secondary metabolites of a hop. |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091010 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 08/15/2006 | US7091007 Comprises nucleotide sequences coding bone morphogenic and serine/threonine receptor proteins for for identifying modulators for use in prevention and treatment of bone and/or cartilage disorders |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7091005 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 08/15/2006 | US7091004 Regulation of translation for recombinant protein production |
| 08/15/2006 | US7091003 Polypeptides having phospholipase B activity and nucleic acids encoding same |
| 08/15/2006 | US7091002 Carboxypeptidases and nucleic acids encoding same |
| 08/15/2006 | US7091001 Process for the preparation of high arginine peptides |
| 08/15/2006 | US7091000 Bacterial strains which overproduce riboflavin and methods of use thereof |
| 08/15/2006 | US7090989 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090985 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 08/15/2006 | US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090847 antibody/fragment binds interleukin or fusion protein; immunology; tissue-targeted therapy |
| 08/15/2006 | US7090844 monoclonal antibody comprising a heavy chain amino acid; treatment of disorders associated with increased activity of MUC18, in particular, tumors, such as melanomas. |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/15/2006 | US7090837 comprises attachment incompetent fusogenic polypeptide (lentivirus or influenza hemagglutinin) and heterologous targeting polypeptide (chimeric, with transmembrane cd40 domain); gag genes/proteins; pol genes/proteins; rev genes/proteins; gene therapy |
| 08/10/2006 | WO2006084226A2 Antibodies that bind to epha2 and methods of use thereof |
| 08/10/2006 | WO2006084111A2 Optimization of heterologous polypeptide expression |
| 08/10/2006 | WO2006083964A2 Modified fusion molecules for treatment of allergic disease |
| 08/10/2006 | WO2006083927A2 Antimicrobial agent |
| 08/10/2006 | WO2006083276A2 Interferon-alpha polypeptides and conjugates |
| 08/10/2006 | WO2006082826A1 METHOD OF IDENTIFYING PURKINJE CELL TARGETING Corl2 GENE |
| 08/10/2006 | WO2006082798A1 Monoclonal antibody specifically recognizing rat type i microglia |
| 08/10/2006 | WO2006082763A1 Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof |
| 08/10/2006 | WO2006026097A3 Pegylation of antibodies against hiv |
| 08/10/2006 | WO2005027962A9 4’-thionucleosides and oligomeric compounds |
| 08/10/2006 | US20060179507 Nucleic acid encoding protein of given sequence; hydroxylation of taxoid; used in production of anti-cancer drugs paclitaxel and taxol |
| 08/10/2006 | US20060179501 Transgenic mice expressing human cd20 |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060178506 Amino acid modified polypeptides |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
| 08/10/2006 | US20060178502 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 08/10/2006 | US20060178337 Method for diagnosing aplasia of corpus callosum |
| 08/10/2006 | US20060178308 Complement inhibitor |
| 08/10/2006 | US20060177917 Process for the production of cellulolytic and hemicellulolytic enzymes using distillation residues from the ethanolic fermentation of enzymatic hydrolyzates of (ligno)cellulosic materials |
| 08/10/2006 | US20060177911 Delta 4,5 glycuronidase and methods of cleaving therewith |
| 08/10/2006 | US20060177909 Preparation of immunoglobulin |
| 08/10/2006 | US20060177908 Il-2 transmembrane construct |
| 08/10/2006 | US20060177907 Methods and materials for characterizing and modulating interaction between heregulin and HER3 |
| 08/10/2006 | US20060177906 IGF-I responsive gene and use thereof |
| 08/10/2006 | US20060177905 UDP-glucosyltransferases |
| 08/10/2006 | US20060177904 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders |
| 08/10/2006 | US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/10/2006 | US20060177902 mammalian cytokine receptor proteins with affinity for IL-13; allergic conditions, asthma, immune complex disease; lupus, nephrotic syndrome, nephritis, glomerulonephritis, thyroiditis and Grave's disease |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177900 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 08/10/2006 | US20060177899 for diagnosis and treatment in receptor-mediated disorders, specifically, cardiovascular diseases, including congestive heart failure |
| 08/10/2006 | US20060177898 Methods for producing modified glycoproteins |
| 08/10/2006 | US20060177897 PR1550 polypeptides and nucleic acids encoding the same |
| 08/10/2006 | US20060177896 Anti-CD3 antibodies and methods of use thereof |
| 08/10/2006 | US20060177895 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA polymerase and thereby prevent the assembly of a poised transcriptional complex |
| 08/10/2006 | US20060177894 Protein knobs |